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In July 2012, the Food and Drug Administration (FDA) 
approved the OraQuick test (OraSure Technologies) as the 
first HIV self-testing kit in the USA.1 This over-the-counter 
test, retailing at approximately US$35 - 40 (R245 - 280), uses 
saliva from a mouth swab and provides a result within 20 - 
40 mins. OraSure has established a consumer support centre 
that provides telephonic support and referrals.2 In a recent 
study of New York-based men who have sex with men (MSM) 
who were provided with the self-testing kit, few experienced 
problems performing the test.3 Studies by the Integration 
of TB in Education and Care for HIV/AIDS (iTEACH) in 
rural KwaZulu-Natal, South Africa (SA), are showing equally 
promising results (K Dong, personal communication). It would 
seem that, with appropriate support, self-testing is poised to 
revolutionise HIV-testing. 
SA has made immense strides in improving HIV testing 
coverage, at least partly owing to direct intervention by the 
Minister of Health.4 However, average CD4 counts at initiation 
of HIV treatment remain low, suggesting that late diagnosis 
may still be a problem for a sizeable proportion of the 
population. New, more convenient ways to test for HIV may 
increase the proportion of individuals who know their HIV 
status, and help to identify infected individuals earlier in the 
course of disease. A recent Lancet editorial notes: ‘Ironically, 
the lack of mandatory counselling with OraQuick may help 
decrease the stigma around testing’.5
Previously, we examined the arguments against self-testing 
and showed that critics’ objections to its roll-out in SA were 
based largely on vague fears with little supporting evidence.6 
Similar conclusions in support of self-testing have been drawn 
by others.7,8 There are a wide range of self-tests currently 
available in pharmacies and supermarkets in SA, including 
tests for pregnancy, prostate cancer, ovulation, recreational 
drugs and breathalysers for alcohol. Few objections have 
been raised against the availability of these tests, and their 
distribution is not regulated. We have argued that self-testing 
in SA may have an enormous positive effect on HIV testing 
uptake and early diagnosis. Self-testing could extend to groups 
that have been traditionally hard to reach with general public 
health campaigns, and would be in line with the spirit of the 
Patients’ Rights Charter and the National Health Act, urging 
people to take responsibility for their own health.6
Yet, SA’s legal and policy frameworks do not facilitate the 
dissemination of HIV self-tests. Self-tests are classified as 
‘medical devices’ under the Medicines and Related Substances 
Control Act (Act no. 101 of 1965, as amended), but there 
is no regulatory system in place yet for medical devices. 
This means, for example, that the manufacturers of the 
OraQuick test would be able to market it in SA – as long 
as the kit, ironically, is not available in pharmacies. The 
only legally binding restriction on the distribution of self-
testing HIV kits is provided by the Good Pharmacy Practice 
(GPP) standards issued by the South African Pharmacy 
Council.9 The 4th edition of the GPP, last updated in 2010, 
prevents pharmacists from selling the test or administering 
it in a pharmacy. Section 2.13.5.5 of the GPP states that ‘only 
rapid tests which use a blood sample may be performed 
in a pharmacy’. Section 2.13.5.8(h) adds that ‘pharmacists 
must not sell HIV tests for patients to perform at home.’ 
Interestingly, this restriction does not apply to any other 
tests. Nor does the GPP apply to general supermarkets or 
corner cafes, creating a loophole for distribution. While the 
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FDA stamp of approval means that the public 
need not be concerned about the accuracy 
of OraQuick if it were to become available 
locally, this would not necessarily hold true 
for other HIV self-tests that are currently 
obtainable at community pharmacies, and 
are left unregulated. Although implementing 
an effective regulatory system for medical 
devices is challenging, unjustified restrictions 
such as those in the GPP could easily be 
addressed.
A recent Civil Society Consensus Statement 
on strategies to improve HIV testing and 
counselling highlighted these and other 
challenges of HIV-testing policies, paradigms 
and legal frameworks in SA.10 The Statement 
endorsed self-testing ‘if accompanied by the 
same essential components of any HIV testing 
service, including easy access to accurate 
information’ and linkages to care. These are 
indeed vital components of the goal to enable 
everyone in SA to test for HIV regularly, and 
to do so when and where they choose. 
Useful websites:
• ‘The first in-home oral HIV test’: http://
www.oraquick.com/home
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